NCT06302933View on ClinicalTrials.gov

Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms

NARecruitingINTERVENTIONAL
Enrollment

451

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

August 30, 2025

Conditions
HIV Infections
Interventions
BIOLOGICAL

Blood sampling

Blood samples collected from children followed in the Pediacam III ANRS12225 cohort

Trial Locations (3)

1274

RECRUITING

Unité Pédiatrique de Jour - Centre Mère et Enfant de la Fondation Chantal Biya, Yaoundé

4035

NOT_YET_RECRUITING

Hôpital de Jour - Hôpital Laquintinie de Douala, Douala

5777

RECRUITING

Service de Pédiatrie - Centre Hospitalier d'Essos, Yaoundé

Sponsors

Collaborators (1)

Institut Pasteur
All Listed Sponsors
collaborator

Centre Pasteur du Cameroun

OTHER

collaborator

Centre Mère et Enfant de la Fondation Chantal Biya

OTHER

collaborator

Centre Hospitalier D'essos

OTHER

collaborator

Hospital General De Douala

OTHER

collaborator

CH Orléans

UNKNOWN

collaborator

Institut Pasteur

INDUSTRY

collaborator

Hopital Universitaire Robert-Debre

OTHER

collaborator

Université Paris-Sud

OTHER

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT06302933 - Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms | Biotech Hunter | Biotech Hunter